Half full, what is needed is a cancer test that only detects fast growing dangerous cancers. A more sensitive test that find even small amounts of slow growing cancers is NOT what is needed.
"A less familiar harm is overdiagnosis, i.e., the diagnosis of a condition that would not have become clinically significant had it not been detected by screening. This harm is becoming more common as screening tests become more sensitive at detecting tiny tumors."
The bocx is correct, there is no way you can win a discussion wiht me for screening using RECAF. IMO, RECAF will NEVER be approved for screening nor will any other universal marker. Even the PSA test is not being recomended for screening use by the doctor that invented it. You probably cannot get a more powerful statement against the use of a marker than that.
There is also no way you can argue that Abbott is proceeding with RECAF. All evidence points to their doing nothing more.
also, I will be totally shocked if Inverness ever attempts to market RECAF. The market for a universal marker is just not there.
